20
Solara Active Pharma Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for API Expertise for more than 30 Years, with 4 Manufacturing Facilities armed with Global Approvals.
One of their notable products is CETIRIZINE HYDROCHLORIDE DIHYDROCHLORIDE USP, with a corresponding US DMF Number 20539.
Remarkably, this DMF maintains an Active status since its submission on May 17, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 07, 2013, and payment made on January 24, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II